We report the treatment response to baricitinib, a JAK‐inhibitor, in a 4‐year‐old girl affected by Aicardi‐Goutières syndrome (AGS2, RNASEH2B mutation). This evidence concerns the gene RNASEH2B and Aicardi-Goutières syndrome.